Evidence summary and rationale: As with Recommendation 1 for SCD patients, no study from the updated review specifically compared limited matching (ABO and RhD) to the RhD, RhCcEe, and K‐matched approach for thalassaemia patients. The gene discussed is ABO; the disease is thalassemia.